Key result
The net consequence of improved survival after acute myocardial infarction due to reperfusion therapy on the subsequent risk of developing heart failure remains uncertain.
Answers are grounded in this paper and cite their sources.
Discusses the theoretical concern that increased survival after acute myocardial infarction due to reperfusion therapy may lead to an increased incidence of heart failure.
Improvements in the treatment of acute myocardial infarction (AMI), especially use of reperfusion therapy, have led to larger numbers of survivors. In patients who would have survived despite reperfusion therapy, use of this treatment should lead to greater myocardial salvage and a reduced extent of ventricular injury in many. However, others who might not have survived previously may now do so, but with substantial left ventricular damage.1,2 The net consequence of these 2 opposing effects on the early and later risk of developing heart failure after AMI is uncertain. There has been concern, however, that an increasing pool of survivors of AMI might fuel an “epidemic” of heart failure.
No takes yet. Share an insight, caveat, or question.
Jhund et al. (2008) conducted an editorial in Acute Myocardial Infarction. Reperfusion therapy was evaluated on Heart failure. The net consequence of improved survival after acute myocardial infarction due to reperfusion therapy on the subsequent risk of developing heart failure remains uncertain.
Synapse has enriched 10 related papers. Consider them for comparative context: